Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

543 ARTÍCULOS , VIENDO DEL 301 AL 315

The Current Landscape of Prevention Trials in Dementia

Lee J, Howard RS, Schneider LS.

Neurotherapeutics. 2022 Jan;19(1):228-247. doi: 10.1007/s13311-022-01236-5. Epub 2022 May 19.

Health Disparities in Dementia

Balls-Berry JJE, Babulal GM.

Continuum (Minneap Minn). 2022 Jun 1;28(3):872-884. doi: 10.1212/CON.0000000000001088.

Process evaluation of the New Interventions for independence in Dementia Study (NIDUS) Family stream randomised controlled trial: protocol

Wyman DL, Butler L, Cooper C, Bright P, Morgan-Trimmer S, Barber J.

BMJ Open. 2022 Jun 9;12(6):e054613. doi: 10.1136/bmjopen-2021-054613.

Evaluating the effectiveness of stepwise swallowing training on dysphagia in patients with Alzheimer's disease: study protocol for a randomized controlled trial

Wu C, Zhang K, Ye J, Huang X, Yang H, Yuan L, Wang H, Wang T, Zhong X, Guo J, Yu L, Xiao A.

Trials. 2022 Jun 13;23(1):490. doi: 10.1186/s13063-022-06446-y.

Study design and protocol of a low to high intensity computer-based cognitive training at home in supplement to standard care in patients with AD

Dimachki S, Tarpin-Bernard F, Croisile B, Chainay H.

BMJ Open. 2022 Jun 20;12(6):e050993. doi: 10.1136/bmjopen-2021-050993.

Curcumin Scaffold as a Multifunctional Tool for Alzheimer's Disease Research

Yang H, Zeng F, Luo Y, Zheng C, Ran C, Yang J.

Molecules. 2022 Jun 17;27(12):3879. doi: 10.3390/molecules27123879.

Near-Infrared Fluorescent Probes as Imaging and Theranostic Modalities for Amyloid-Beta and Tau Aggregates in Alzheimer's Disease

Rai H, Gupta S, Kumar S, Yang J, Singh SK, Ran C, Modi G.

J Med Chem. 2022 Jul 14;65(13):8550-8595. doi: 10.1021/acs.jmedchem.1c01619. Epub 2022 Jun 27.

The road to precision medicine: Eliminating the "One Size Fits All" approach in Alzheimer's disease

Behl T, Kaur I, Sehgal A, Singh S, Albarrati A, Albratty M, Najmi A, Meraya AM, Bungau S.

Biomed Pharmacother. 2022 Sep;153:113337. doi: 10.1016/j.biopha.2022.113337. Epub 2022 Jun 30.

Dementia risk and dynamic response to exercise: A non-randomized clinical trial

Vidoni ED, Morris JK, Palmer JA, Li Y, White D, Kueck PJ, John CS, Honea RA, Lepping RJ, Lee P, Mahnken JD, Martin LE, Billinger SA.

PLoS One. 2022 Jul 8;17(7):e0265860. doi: 10.1371/journal.pone.0265860. eCollection 2022.

Parietal-hippocampal rTMS improves cognitive function in Alzheimer's disease and increases dynamic functional connectivity of default mode network

Wei L, Zhang Y, Wang J, Xu L, Yang K, Lv X, Zhu Z, Gong Q, Hu W, Li X, Qian M, Shen Y, Chen W.

Psychiatry Res. 2022 Sep;315:114721. doi: 10.1016/j.psychres.2022.114721. Epub 2022 Jul 8.

Clinical Trial Endpoints and Their Clinical Meaningfulness in Early Stages of Alzheimer's Disease

Cohen S, Cummings J, Knox S, Potashman M, Harrison J.

J Prev Alzheimers Dis. 2022;9(3):507-522. doi: 10.14283/jpad.2022.41.

The promise of music therapy for Alzheimer's disease: A review

Matziorinis AM, Koelsch S.

Ann N Y Acad Sci. 2022 Oct;1516(1):11-17. doi: 10.1111/nyas.14864. Epub 2022 Jul 18.

Neuroimaging analyses from a randomized, controlled study to evaluate plasma exchange with albumin replacement in mild-to-moderate Alzheimer's disease: additional results from the AMBAR study

Cuberas-Borrós G, Roca I, Castell-Conesa J, Núñez L, Boada M, López OL, Grifols C, Barceló M, Pareto D, Páez A.

Eur J Nucl Med Mol Imaging. 2022 Nov;49(13):4589-4600. doi: 10.1007/s00259-022-05915-5. Epub 2022 Jul 22.

Ceramide/Sphingosine 1-Phosphate Axis as a Key Target for Diagnosis and Treatment in Alzheimer's Disease and Other Neurodegenerative Diseases

Custodia A, Romaus-Sanjurjo D, Aramburu-Núñez M, Álvarez-Rafael D, Vázquez-Vázquez L, Camino-Castiñeiras J, Leira Y, Pías-Peleteiro JM, Aldrey JM, Sobrino T, Ouro A.

Int J Mol Sci. 2022 Jul 22;23(15):8082. doi: 10.3390/ijms23158082.

Noradrenergic Add-on Therapy with Extended-Release Guanfacine in Alzheimer's Disease (NorAD): study protocol for a randomised clinical trial and COVID-19 amendments

Hoang K, Watt H, Golemme M, Perry RJ, Ritchie C, Wilson D, Pickett J, Fox C, Howard R, Malhotra PA.

Trials. 2022 Aug 1;23(1):623. doi: 10.1186/s13063-022-06190-3.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias